drugset / Trial / NCT04680143
Systemic Erythropoietin Injection in Patients Having Optic Atrophy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 10000 iu | Subcutaneous |